Tag

Amylin

All articles tagged with #amylin

health-and-pharma2 hours ago•1 min saved

Novo Nordisk reports 25% weight loss for CagriSema in women

Novo Nordisk released new post-trial data showing its experimental combination drug CagriSema achieved an average 25% weight loss in women at 68 weeks. The results, based on an ideal adherence scenario, suggest the drug may outperform its current blockbuster, Wegovy, particularly for women across various menopausal stages. While the data supports efficacy, Wall Street remains cautious due to previous trial disappointments, though analysts project significant future sales.

via CNBC|

#amylin #cagrisema #glp-1

health-and-science18 days ago•3 min saved

Amylin and Triple-Agonist Trials Signal Next Wave in Obesity Treatment

Eli Lilly and Novo Nordisk are advancing next-generation obesity treatments targeting the amylin pathway and multiple hormone receptors. Lilly’s Phase 2 trial showed its amylin drug eloralintide, combined with tirzepatide, achieved 23.3% weight loss, though side effects caused higher discontinuation rates. Meanwhile, Lilly’s triple-agonist retatrutide reached a Phase 3 milestone, with 12mg doses yielding 18.8% weight loss and improved metabolic markers in diabetic patients. Novo is preparing to launch its amylin-based CagriSema next year. These developments aim to address patients who do not respond adequately to current GLP-1 therapies, expanding treatment options through multi-pathway approaches.

via CNBC|

#amylin #eli-lilly #health-and-science

health-and-science20 days ago•2 min saved

Lilly's amylin-tirzepatide combo hits 23% weight loss in Phase 2 trial

Eli Lilly reported that its experimental combination of the amylin-targeting drug eloralintide and its existing GLP-1/GIP drug tirzepatide produced superior weight loss in a mid-stage trial. Patients with obesity and Type 2 diabetes lost up to 23.3% of their body weight over 48 weeks, outperforming tirzepatide alone. While the results are promising, higher discontinuation rates due to side effects raised questions about tolerability. Lilly plans to advance the therapy to Phase 3 trials by the end of 2026.

via CNBC|

#amylin #clinical-trials #eli-lilly

health11 months ago•2 min saved

Eli Lilly's New Weight Loss Drug Advances to Late-Stage Trials After Promising Results

Eli Lilly's experimental obesity drug, eloralintide, shows promising results in mid-stage trials, with significant weight loss and improved health markers, leading to plans for late-stage trials and potential as an alternative to existing therapies.

via NBC News|

#amylin #eli-lilly #health

health1 year ago•4 min saved

Scientists Find New Hormone Promising for Weight-Loss Treatments

Scientists have discovered new insights into the hormone amylin, which could lead to more effective weight-loss medications by better understanding its receptors, potentially speeding up the development of next-generation obesity drugs like amylin-based treatments currently in trials.

via bestlifeonline.com|

#amylin #health #hormone

health1 year ago•1 min saved

Novo Nordisk's New Weight-Loss Pill Shows Promising Results

Novo Nordisk's new amylin-based obesity drug, amycretin, shows significant weight loss in early trials, but similar efficacy across different doses and high side effects raise questions about optimal dosing strategies.

via STAT|

#amylin #drug-dosing #health

biotech1 year ago•1 min saved

Metsera's Monthly Weight Loss Drug Shows Promising Early Results

Metsera's experimental drug targeting the amylin hormone showed promising results in early clinical trials, indicating potential for longer-lasting weight loss effects compared to existing weekly injections, highlighting a significant development in obesity treatment.

via statnews.com|

#amylin #biotech #clinical-trial

health1 year ago•1 min saved

Metsera's Amylin Drug Shows Promising Weight Loss Results

Metsera's experimental obesity drug targeting amylin shows promising early results, with significant weight loss observed in initial trials, suggesting it may offer longer-lasting effects than current weekly injections.

via statnews.com|

#amylin #clinical-trial #health